Literature DB >> 29874121

CD40 as a therapeutic target in Sjögren's syndrome.

Kerry Jobling1, Wan Fai Ng2.   

Abstract

Entities:  

Keywords:  CD40; CD40L; Primary Sjögren’s syndrome; co-stimulation; monoclonal antibody

Mesh:

Substances:

Year:  2018        PMID: 29874121     DOI: 10.1080/1744666X.2018.1485492

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  2 in total

Review 1.  B cell dysregulation in primary Sjögren's syndrome: A review.

Authors:  Hazim Mahmoud Ibrahem
Journal:  Jpn Dent Sci Rev       Date:  2019-10-21

2.  CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer.

Authors:  Chenshuo Luo; Ting Lei; Man Zhao; Qian Meng; Man Zhang
Journal:  J Oncol       Date:  2020-04-28       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.